NTES-S
09999
BIDU-SW
09888
JD-SW
09618
BOSS ZHIPIN-W
02076
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||
Earning before tax | ---- | 51.42%282.15M | ---- | -9.87%186.34M | ---- | 43.64%206.73M | -20.84%143.93M | --181.83M |
Profit adjustment | ||||||||
Interest (income) - adjustment | ---- | 30.72%-18.23M | ---- | 10.36%-26.31M | ---- | -11.22%-29.35M | -1.19%-26.39M | ---26.08M |
Interest expense - adjustment | ---- | -40.08%50.37M | ---- | 3.14%84.07M | ---- | -12.24%81.5M | 13.53%92.87M | --81.8M |
Investment loss (gain) | ---- | ---- | ---- | 65.07%-146K | ---- | 65.37%-418K | -413.62%-1.21M | ---235K |
Attributable subsidiary (profit) loss | ---- | -13.56%-15.37M | ---- | -13.19%-13.54M | ---- | -28.85%-11.96M | -175.84%-9.28M | ---3.37M |
Impairment and provisions: | ---- | 12.68%-11.98M | ---- | -1,278.89%-13.72M | ---- | -107.34%-995K | 2,063.48%13.55M | ---690K |
-Other impairments and provisions | ---- | 12.68%-11.98M | ---- | -1,278.89%-13.72M | ---- | -107.34%-995K | 2,063.48%13.55M | ---690K |
Revaluation surplus: | ---- | -24.91%3.98M | ---- | 165.00%5.3M | ---- | -68.25%2M | 171.59%6.3M | ---8.8M |
-Fair value of investment properties (increase) | ---- | -24.91%3.98M | ---- | 165.00%5.3M | ---- | -68.25%2M | 171.59%6.3M | ---8.8M |
Asset sale loss (gain): | ---- | 31.82%-932K | ---- | -293.95%-1.37M | ---- | 90.13%-347K | 46.31%-3.52M | ---6.55M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | -875.00%-39K | ---- | 94.44%-4K | ---72K | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -285.12%-932K | ---- | -303.36%-242K | ---- | 103.46%119K | -4,150.62%-3.44M | ---81K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | -135.06%-1.09M | ---- | ---462K | ---- | ---6.47M |
Depreciation and amortization: | ---- | 4.94%205.81M | ---- | 4.53%196.11M | ---- | 12.52%187.62M | 10.25%166.74M | --151.24M |
-Amortization of intangible assets | ---- | 2.96%200.71M | ---- | 5.78%194.93M | ---- | 10.98%184.28M | 9.75%166.05M | --151.3M |
-Other depreciation and amortization | ---- | 15.68%-15.74M | ---- | -31.40%-18.67M | ---- | -1.95%-14.21M | -1.64%-13.93M | ---13.71M |
Special items | ---- | 18.51%-28.15M | ---- | -15.23%-34.55M | ---- | 35.62%-29.98M | -11.17%-46.57M | ---41.89M |
Operating profit before the change of operating capital | ---- | 22.36%467.64M | ---- | -5.59%382.18M | ---- | 20.33%404.8M | 2.80%336.41M | --327.26M |
Change of operating capital | ||||||||
Inventory (increase) decrease | ---- | 212.16%12.06M | ---- | -103.64%-10.75M | ---- | -146.81%-5.28M | 369.54%11.28M | ---4.18M |
Accounts receivable (increase)decrease | ---- | -668.43%-90.42M | ---- | 280.86%15.91M | ---- | 69.37%-8.8M | 53.17%-28.71M | ---61.31M |
Accounts payable increase (decrease) | ---- | 7.94%137.45M | ---- | 1,219.35%127.34M | ---- | 74.59%-11.38M | 35.65%-44.77M | ---69.57M |
Special items for working capital changes | ---- | 28.79%210.09M | ---- | 3.24%163.12M | ---- | -23.74%158M | 35.63%207.19M | --152.76M |
Cash from business operations | -268.32%-113.02M | 8.71%736.81M | -50.34%67.15M | 26.14%677.8M | --135.22M | 11.62%537.35M | 39.56%481.4M | --344.95M |
Other taxs | -3.65%-41.75M | -3.22%-61.89M | -0.17%-40.28M | -60.66%-59.96M | ---40.21M | 3.96%-37.32M | -20.29%-38.86M | ---32.31M |
Net cash from operations | -676.09%-154.77M | 9.24%674.92M | -71.72%26.87M | 23.56%617.84M | --95.01M | 12.99%500.03M | 41.55%442.54M | --312.64M |
Cash flow from investment activities | ||||||||
Interest received - investment | 103.59%3.97M | 62.74%5.2M | 33.63%1.95M | -76.75%3.19M | --1.46M | 445.45%13.74M | 22.40%2.52M | --2.06M |
Dividend received - investment | ---- | ---- | ---- | --3.2M | --3.2M | ---- | --3.68M | ---- |
Restricted cash (increase) decrease | ---- | ---- | ---- | 200.00%38.83M | --38.83M | ---38.83M | ---- | ---- |
Loan receivable (increase) decrease | ---- | -49.04%36.18M | ---- | -61.30%70.98M | --40M | 254.10%183.41M | ---119.02M | ---- |
Sale of fixed assets | 37.50%33K | 435.16%4.38M | -96.13%24K | 3,800.00%819K | --620K | -99.44%21K | 2,960.98%3.77M | --123K |
Purchase of fixed assets | 88.46%-1.88M | -39.74%-21.28M | -897.48%-16.26M | -220.52%-15.23M | ---1.63M | 91.75%-4.75M | -67.12%-57.61M | ---34.47M |
Selling intangible assets | ---- | ---- | ---- | 211.04%15.55M | --15.55M | -85.83%5M | 62.77%35.28M | --21.68M |
Purchase of intangible assets | -18.69%-167.55M | -6.96%-292.73M | 45.22%-141.17M | 8.87%-273.69M | ---257.69M | -41.02%-300.33M | 21.09%-212.97M | ---269.88M |
Recovery of cash from investments | ---- | ---- | ---- | -61.74%27.29M | --27.28M | -90.47%71.32M | 917.07%748.14M | --73.56M |
Cash on investment | ---- | ---- | ---- | 87.01%-10M | ---10M | 89.65%-77M | -1,046.57%-743.93M | ---64.88M |
Other items in the investment business | 18.00%31.21M | 3.79%22M | 16.51%26.45M | -56.47%21.2M | --22.7M | --48.7M | ---- | ---18.69M |
Net cash from investment operations | -4.04%-134.21M | -108.94%-246.26M | -7.79%-129M | -19.38%-117.86M | ---119.68M | 70.97%-98.73M | -17.08%-340.14M | ---290.51M |
Net cash before financing | -182.95%-288.98M | -14.26%428.66M | -313.96%-102.13M | 24.59%499.98M | ---24.67M | 291.87%401.3M | 362.66%102.41M | --22.13M |
Cash flow from financing activities | ||||||||
New borrowing | 5.74%232.56M | -73.95%220.35M | -73.66%219.95M | 68.87%846.01M | --835M | -49.66%501M | 25.30%995.2M | --794.25M |
Refund | -2.52%-223.79M | 61.09%-382.56M | 66.93%-218.27M | -31.01%-983.08M | ---660.09M | 13.32%-750.36M | -14.69%-865.65M | ---754.78M |
Issuing shares | ---- | --238.84M | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | 8.79%-21.85M | 27.87%-48.12M | 32.14%-23.96M | 16.14%-66.72M | ---35.31M | 11.87%-79.56M | -12.86%-90.27M | ---79.99M |
Dividends paid - financing | -452.40%-55.24M | ---60.78M | ---10M | ---- | ---- | ---- | -426.96%-13.29M | ---2.52M |
Absorb investment income | --10M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | -13.70%-23.62M | 25.70%-8.48M | -116.45%-20.78M | ---11.41M | -229.07%-9.6M | ---2.92M | ---- |
Other items of the financing business | 31.43%-19.56M | -11.94%-33.77M | 58.74%-28.52M | -109.38%-30.17M | ---69.12M | 83.00%-14.41M | -88.88%-84.75M | ---44.87M |
Net cash from financing operations | -12.02%-78.18M | 63.75%-93.56M | -219.43%-69.79M | 27.69%-258.1M | --58.44M | -434.71%-356.94M | 25.30%-66.76M | ---89.36M |
Net Cash | -113.56%-367.16M | 38.54%335.11M | -609.19%-171.92M | 445.29%241.88M | --33.76M | 24.43%44.36M | 153.03%35.65M | ---67.23M |
Begining period cash | 88.64%713.18M | 177.61%378.07M | 177.61%378.07M | 48.31%136.19M | --136.19M | 63.46%91.83M | -54.48%56.18M | --123.41M |
Cash at the end | 67.85%346.02M | 88.64%713.18M | 21.30%206.15M | 177.61%378.07M | --169.95M | 48.31%136.19M | 63.46%91.83M | --56.18M |
Cash balance analysis | ||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.